Ultimate Guide to Combating Coronavirus Ultimate Guide to Combating Coronavirus

ADVERTISEMENT

The National Plan to Vaccinate Every American

Analysis by Barbara Loe Fisher Fact Checked

Story at-a-glance -

  • The coronavirus vaccine may be the first genetically engineered messenger RNA vaccine to be fast tracked to licensure
  • The FDA has not yet licensed messenger RNA vaccines that use part of the RNA of a virus to manipulate the body’s immune system into stimulating a potent immune response
  • There likely will be lots of questions about whether the fast-tracked coronavirus vaccine was studied long enough to adequately demonstrate safety
  • The U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) may recommend that all Americans get the newly licensed coronavirus vaccine
  • The government has a National Vaccine Plan designed to make sure you, your child and everyone in America gets every dose of every vaccine that government officials recommend now and in the future

Scientists at the National Institutes of Health are working with a biotech company to quickly start clinical trials of an experimental messenger RNA vaccine and fast track it to licensure. The FDA has not yet licensed messenger RNA vaccines that use part of the RNA of a virus to manipulate the body’s immune system into stimulating a potent immune response.

It looks like the coronavirus vaccine will be the first genetically engineered messenger RNA vaccine to be fast tracked to licensure, just like Gardasil was the first genetically engineered virus-like particle vaccine to be fast tracked to licensure.


Read the Full Article for Free!
Subscribe to the #1 Natural Health Newsletter
  • Unlock censored health information that Google doesn't want you to read
  • Keep your privacy secure — We are no longer active on Facebook and are blocking our content from Google search to ensure your privacy stays protected
  • Get access to all of Dr. Mercola's health articles, E-books and special reports

Existing Subscribers: Enter your email address for instant access